Treatment of Secondary Raw Materials by Innovative Processes

This paper presents an overview of the various innovative methodologies used in the recovery of valuable metals and critical raw materials from secondary sources. The review also highlights the used varieties of application on large scale in real situations and hopes to provide insights into valorization of spent sources

Application of Innovative Processes for Gold Recovery from Romanian Mining Wastes

The application of a new hydrometallurgical process for gold extraction by thiosulphate leaching from Romanian mining wastes, coming from Balan and Deva deposits, was studied. There was obtained 85% of Au extraction after leaching; moreover, an integrated flow-sheet, including recycling of process solution and carbon, was outlined, based on results obtained at a laboratory scale, using a schematic chemical circuit of treatment. Global recovery of the process (leaching-adsorption-desorption-electrodeposition) of about 75-80% of Au was achieved. The developed integrated flow-sheet, allows to recycle the reagents during the process, with a loss of only 5-10%, in particular thiosulphate and alcohol, for each complete circuit of treatment

Thyroid cell transformation inhibits the expression of a novel rat protein tyrosine phosphatase.

We have isolated a rat thyroid cDNA encoding a novel rat receptor-type tyrosine phosphatase protein. This gene, on the basis of its homology to another tyrosine phosphatase, the recently isolated human DEP-1/HPTP eta, has been named r-PTP eta. In rat thyroid cells the r-PTP eta gene acts as a differentiation marker, Indeed, the block of thyroid cell differentiation induced by viral and cellular oncogenes is associated with the inhibition or marked reduction of the expression of this gene and its expression is positively regulated by thyrotropin, the physiological stimulator of thyroid cell growth. (C) 1997 Academic Press

Nuclear BMI-1 expression in laryngeal carcinoma correlates with lymph node pathological status

<p>Abstract</p> <p>Background</p> <p>The main cause of treatment failure and death in laryngeal squamous cell carcinoma is metastasis to the regional lymph nodes. The current clinical staging criteria fail to differentiate patients with occult metastasis from patients without metastasis. Identifying molecular markers of the disease might improve our understanding of the molecular mechanisms underlying the pathogenesis and development of laryngeal carcinoma and may help improve clinical staging and treatment.</p> <p>Methods</p> <p>Sixty-four previously untreated patients who underwent surgical excision of laryngeal squamous cell carcinoma with neck dissection were included in this study. The expression of B cell-specific Moloney murine leukemia virus integration site 1 (BMI-1) was examined immunohistochemically on formalin-fixed paraffin-embedded primary tissue specimens.</p> <p>Results</p> <p>Nuclear expression of BMI-1 (nBMI-1) was detected in 32 of the 64 tumors (50%), cytoplasmic expression of BMI-1 (cBMI-1) was detected in 22 (34.4%), and 10 tumors (15.6%) showed no BMI-1 immunoreactivity. High nBMI-1 expression levels (≥10) were detected in 28 of the 32 (87.5%) nBMI-1-positive patients. Multivariate analysis including age at diagnosis, grade, tumor location, TNM status, and nBMI-1 expression showed that a high nBMI-1 expression level was an independent prognostic factor for lymph node metastasis.</p> <p>Conclusion</p> <p>The expression of BMI-1 in patients with laryngeal carcinoma seems to correlate with lymph node metastasis.</p